Furthermore, the downstream CG probesets of SLC22A17, including the 3′UTR CG probeset, were associated with worse prognosis in HNSC (n = 5) and ACC (n = 3) (Figure 14; Supplementary Table S13). This evidence concerns the gene SLC22A17 and adrenal cortex carcinoma.